Adenoma ; classification ; pathology ; Carcinoma in Situ ; classification ; pathology ; Carcinoma, Squamous Cell ; classification ; pathology ; Colorectal Neoplasms ; classification ; pathology ; Esophageal Neoplasms ; classification ; pathology ; Gastrointestinal Neoplasms ; classification ; pathology ; Humans ; Hyperplasia ; classification ; pathology ; Neoplasm Staging ; Precancerous Conditions ; classification ; pathology ; Stomach Neoplasms ; classification ; pathology ; World Health Organization

Carcinoma, Endometrioid ; diagnosis ; Dilatation and Curettage ; methods ; Endometrial Neoplasms ; diagnosis ; Endometrium ; pathology ; Female ; Humans

Adenocarcinoma ; classification ; diagnosis ; metabolism ; Humans ; Immunohistochemistry ; International Agencies ; Lung Neoplasms ; classification ; diagnosis ; metabolism ; Neoplasm Invasiveness ; Societies, Medical ; United States

Breast ; pathology ; Carcinoma, Intraductal, Noninfiltrating ; diagnosis ; metabolism ; pathology ; Female ; Humans ; Hyperplasia ; metabolism ; pathology ; Keratin-5 ; metabolism ; Keratin-6 ; metabolism ; Precancerous Conditions ; diagnosis ; metabolism ; pathology ; Stem Cells ; metabolism ; pathology

Adenocarcinoma, Mucinous ; diagnosis ; pathology ; Cystadenocarcinoma, Mucinous ; diagnosis ; pathology ; Diagnosis, Differential ; Female ; Humans ; Ovarian Neoplasms ; pathology ; Ovary ; pathology

Adult ; Epithelioid Cells ; pathology ; Humans ; Male ; Perivascular Epithelioid Cell Neoplasms ; pathology

Cystadenocarcinoma, Serous ; diagnosis ; pathology ; Female ; Humans ; Ovary ; pathology

Adenocarcinoma ; classification ; pathology ; Endometrial Hyperplasia ; classification ; pathology ; Endometrial Neoplasms ; classification ; pathology ; Female ; Humans ; Neoplasm Invasiveness ; Neoplasm Staging ; Polyps ; pathology ; Precancerous Conditions ; classification ; pathology ; World Health Organization

Carcinoma, Papillary ; classification ; pathology ; surgery ; Humans ; Neoplasm Recurrence, Local ; Urinary Bladder Neoplasms ; classification ; pathology ; surgery ; Urothelium ; pathology ; surgery ; World Health Organization

Objective To study the clinical therapeutic effectiveness and the mechanism of Shouti Oral Liquid on simple obesity children with hyperinsulinism. Methods Fourty - three patients were divided randomly into the treatment group (TG) and the control group (CG). TG took Shouti Oral Liquid and CG took metformin. The course of therapy lasted 6 months. The plasma lipid, body fats, insulin resistance index (IR) and some hormones related to obesity before and after therapy were measured and the changes were analyzed. Results The weight, F% , body mass index (BMI), leptin(LP), tumor necrosing factor (TNF - ?), FINS, IR all declined markedly than pre - therapy in both groups. The significant effect, normal effect and total efficiency were 22.7 % , 59.1 %, 81.8 % respectively in TG and9.5%,52.4%,61.9% in CG. The effect in TG was better than that in CG. A short course with Shouti Oral Liquid therapy did not have obvious side effect Conclusions There are lipid metabolism disorder, insulin resistance and high lever LP and TNF - ? obesity children with hyperinsulinism. The total effect with Shouti Oral Liquid is better than that with medicine in the control group and the mechanism was regulating lipid metabolism, decreasing LP and TNF-? and ameliorating insulin resistance.